W8M-MC-LAA2 4+
Medable, Inc.
Designed for iPad
-
- Free
Screenshots
Description
A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management with LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants with Obesity or Overweight with T2D
What’s New
Version 1.2
Minor bug fix.
App Privacy
The developer, Medable, Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Linked to You
The following data may be collected and linked to your identity:
- Health & Fitness
- Contact Info
- Identifiers
- Diagnostics
Privacy practices may vary, for example, based on the features you use or your age. Learn More
Information
- Seller
- Medable, Inc.
- Size
- 105.3 MB
- Category
- Health & Fitness
- Compatibility
-
- iPhone
- Requires iOS 14.0 or later.
- iPad
- Requires iPadOS 14.0 or later.
- iPod touch
- Requires iOS 14.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English, Afrikaans, Arabic, Assamese, Bengali, Bulgarian, Catalan, Cebuano, Croatian, Czech, Danish, Dutch, Estonian, Filipino, Finnish, French, Galician, Georgian, German, Greek, Gujarati, Haitian, Hebrew, Hiligaynon, Hindi, Hungarian, Iloko, Italian, Japanese, Kannada, Korean, Latvian, Lithuanian, Malay, Malayalam, Marathi, Norwegian Bokmål, Oriya, Pedi, Polish, Portuguese, Punjabi, Romanian, Russian, Serbian, Sesotho, Setswana, Simplified Chinese, Slovak, Slovenian, Spanish, Swedish, Tamil, Telugu, Thai, Traditional Chinese, Turkish, Ukrainian, Urdu, Vietnamese, Xhosa, Zulu
- Age Rating
- 4+
- Copyright
- © Medable, Inc.
- Price
- Free